Navigation Links
Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
Date:4/16/2008

ords, and similar expressions also identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. The forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Factors that could affect actual results include risks associated with unexpected delays in clinical trials and preclinical studies and the timing for making related regulatory filings; the fact that data from preclinical studies and Phase 1 or Phase 2 clinical trials may not necessarily be indicative of future clinical trial results; our ability to estimate accurately the amount of cash to be used to fund operations over the next 12 months, our ability to obtain future financing and fund the product development of our pipeline; the initiation, timing, design, enrollment and cost of clinical trails and preclinical studies; our ability to establish successful partnerships and collaborations with third parties; the regulatory approval process in the United States and other countries; and our future capital requirements. For further information about these risks and other factors that may affect the actual results achieved by Pharmacyclics, please see the company's reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its annual report on Form 10-K for the period ended June 30, 2007 and its subsequently filed quarterly reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
4. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
5. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
6. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
7. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
8. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
9. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
10. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
11. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015  SeraCare Life Sciences, a leading partner ... at the American Association of Clinical Chemistry (AACC) ... with the University of California, San Francisco (UCSF) ... 18 (T18) and Trisomy 13 (T13) trophoblast cell ... reference materials for Non-Invasive Prenatal Testing (NIPT) of ...
(Date:7/28/2015)... 28, 2015 At the 2015 ... Association recognized 15 winners in the categories of ... across multiple vertical markets. ContextMedia:Health proudly took ... for its success with its first-to-market Patient ... ContextMedia:Health, the leading provider of digital solutions ...
(Date:7/28/2015)... Transparency Market Research (TMR) has announced ... Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, ... to this report, the global cancer diagnostics market is expected ... period of 2014 to 2020. In 2013, the global cancer ... to be worth US$168,649.3 million by 2020.The increasing prevalence of ...
Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3ContextMedia:Health Receives Top Award at the ICX Association Excellence Awards 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4
... N.J., Oct. 27 Laureate Pharma, Inc., ... announced today that they have entered into ... AV-203, AVEO Pharmaceutical,s (Cambridge, MA) novel monoclonal ... include process development, protein production, purification and ...
... Samplify Systems, Inc., a leading ... solutions for the medical imaging market, today introduces ... on Samplify,s AutoFocus™ beamforming technology, the SMK9130 is ... end, from probe connector to PCIe connector.  The ...
Cached Medicine Technology:Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals' Antibody Therapeutic 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 3
(Date:7/29/2015)... ... July 29, 2015 , ... Zofran ... Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* Attorneys handling ... website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate ...
(Date:7/29/2015)... ... July 29, 2015 , ... The New Foundation AZ recently started ... end will cost the 501(c) organization nearly $1 million, will both update the facilities’ ... “We took it down to the studs,” said Geraldine Leary, the New Foundation AZ ...
(Date:7/29/2015)... ... 2015 , ... The Woodlands and Spring Fit Body Boot Camps have implemented ... causes each month. The new system will track each time a client uses social ... each facility, the boot camps will donate 20 cents to a selected charity. , ...
(Date:7/29/2015)... MN (PRWEB) , ... July 29, 2015 , ... ... announces that it has entered into a partnership with 247Ergo, an ergonomics specialty ... health and wellness. Ergonomics projects that the companies undertake could improve worker mobility, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for basketball, ... the home of Zerorez Indianapolis, which plans to expand across the state. , Ray ... our second full year in business and we should double our first year’s revenue. ...
Breaking Medicine News(10 mins):Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3
... to coincide with the 19th anniversary of the adoption of the ... , ARLINGTON, Va., Nov. 19 The ... of the Convention on the Rights of the Child (CRC), the ... a Senate Staff Briefing on Children,s Health Issues and The Convention ...
... A new study by researchers at the Bradley Hasbro Children,s ... is increasing among teens and young adults particularly those ... recent data that show anal sex rates among adults doubled ... online by the American Journal of Public Health , ...
... Treatment Centers poll examines "not-so-merry" workplace and family holiday parties ... PHILADELPHIA, Nov. 19 From sexual antics ... alcohol fuels a number of "bad behaviors" at workplace and ... Caron Treatment Centers , one of the nation,s leading ...
... Disease in Washington, DC Area , , ... Kidney Foundation: , , WHO: ... Guests - 1,000 of the Washington area,s ... Special Guests - Alonzo Mourning, kidney transplant recipient, ...
... initiative aims to engage 6th to 8th grade youth in groundbreaking ... and abuse , , Blue Shield ... the largest national investments ever made to prevent teen dating violence ... N.J., Nov. 19 The Robert Wood Johnson Foundation ...
... URAC,s Comprehensive Wellness Accreditation standards , ... today that its Board of Directors has approved standards ... These innovative standards reinforce and support the commitment that ... and productivity of America,s workforce. Comprehensive Wellness is ...
Cached Medicine News:Health News:Linda Spears, CWLA Vice President of Policy Will Speak at Senate Briefing 2Health News:More at-risk teens and young adults engaging in anal intercourse 2Health News:Sex, Lies and Other Alcohol-Fueled 'Bad Behavior' 2Health News:Sex, Lies and Other Alcohol-Fueled 'Bad Behavior' 3Health News:Sex, Lies and Other Alcohol-Fueled 'Bad Behavior' 4Health News:Sex, Lies and Other Alcohol-Fueled 'Bad Behavior' 5Health News:Sex, Lies and Other Alcohol-Fueled 'Bad Behavior' 6Health News:Sex, Lies and Other Alcohol-Fueled 'Bad Behavior' 7Health News:Special Guest Alonzo Mourning to Attend National Kidney Foundation's 28th Annual Kidney Ball Featuring Entertainment by the Doobie Brothers 2Health News:Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence 2Health News:Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence 3Health News:Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence 4Health News:Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence 5Health News:Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence 6Health News:Robert Wood Johnson Foundation Announces Grant Recipients for $18 Million Dollar Initiative to Prevent Intimate Partner Violence 7Health News:URAC Announces Accreditation Standards for Comprehensive Wellness Programs 2Health News:URAC Announces Accreditation Standards for Comprehensive Wellness Programs 3Health News:URAC Announces Accreditation Standards for Comprehensive Wellness Programs 4
... disposable template is designed for ... eliminate the need for cleaning. ... premium silicone molded over a ... needle placement while maintaining needle ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... Reusable Template is designed for use ... system for prostate brachytherapy. Please be ... software match the graphics on the ... pins protruding from lower surface which ...
... latest introduction in the family of positioners ... of the stepping platform features a top-loading ... The EXII steeping unit has a digital ... display of transducer position and a serial ...
Medicine Products: